Introduction
============

Among the various bacterial etiologic agents involved in the genesis of community-acquired pneumonia (CAP), *Streptococcus pneumoniae* is the main cause of the disease in children and adults. Currently, there are reports of 91 serotypes[@B1] ^,^ [@B2] associated with CAP and other diseases. However, CAP causes greater morbidity and its occurrence is estimated at 13.8 million new cases worldwide each year.[@B3] ^,^ [@B4]

Between 6% and 16% of CAP cases require hospitalization, and in children under age five, the disease, particularly of bacterial etiology, accounts for 20-40% of admissions only in the Americas.[@B4] In Brazil, between 2004 and 2006, pneumococcal diseases were responsible for about 34,000 hospitalizations.

The global estimate of CAP incidence among children aged 1-5 years in developing countries is 0.29 episodes per child-year. This is equivalent to an annual incidence of about 150 million cases; 11-20% of these cases require hospitalization.[@B4] In Brazil, according to the Hospital Information System (SIH-SUS), from January 2005 to March 2006, CAP accounted for about 20% of the hospitalizations of children under age five.[@B5] ^-^ [@B7]

Consensually, preventive measures are the best way to reduce the incidence of pneumococcal disease and its consequences, such as hospitalization and premature death.[@B5] Among these measures, active immunization against the main causative agents, particularly certain serotypes of *Streptococcus pneumoniae*, has proven highly efficient over the years in reducing the occurrence of severe disease.[@B5] ^,^ [@B6]

In Brazil, with the incorporation of pneumococcal vaccines, particularly 10-valent, since 2010,[@B6] ^,^ [@B7] there is a reduction of pneumococcal diseases, such as meningitis and CAP,[@B8] ^-^ [@B10] in children under two years of age, with a decline in the number of hospitalizations, malnutrition, deaths, and parental work absenteeism, as well as cost reduction, among others.[@B11] ^,^ [@B12]

The aim of the present paper was to evaluate the impact of 10-valent pneumococcal conjugate vaccine (PCV-10) before booster shot in hospitalized children under one year of age with CAP, before and after its introduction in the National Immunization Program (PNI) in municipalities belonging to the Regional Health Superintendence of Alfenas (SRS/Alfenas, MG, Brazil).

Method
======

This is an ecological study including records of children under one year old who received or not 10-valent pneumococcal conjugate vaccine in the period before and after its inclusion in the PNI, in which vaccination was considered as the exposure factor and CAP hospitalization as the endpoint. The study used secondary annual data by municipality to calculate vaccination coverage and pneumonia morbidity rates in children under one year old from 2007 to 2013. Comparison of raw numbers (i.e., non-proportional numbers) of CAP hospitalization from 2007 to 2013 in the municipalities belonging to SRS/Alfenas was performed.

We assessed records of children up to one year old, living in 26 municipalities under the jurisdiction of SRS/Alfenas---State Department of Health of Minas Gerais, Brazil. Data were collected through search in the Information System of the National Immunization Program (SI-PNI)[@B13] and Tabwin database available in the Regulation Center of SRS/Alfenas, MG. The municipalities belonging to SRS/Alfenas are: Alfenas, Alterosa, Arceburgo, Areado, Bandeira do Sul, Botelhos, Cabo Verde, Campestre, Campo do Meio, Campos Gerais, Carmo do Rio Claro, Carvalhópolis, Conceição da Aparecida, Divisa Nova, Fama, Guaranésia, Guaxupé, Juruaia, Machado, Monte Belo, Muzambinho, Nova Resende, Paraguaçu, Poço Fundo, São Pedro da União, and Serrania.

During the period mentioned above, the entire child population was included. To verify the association between variables (independent and response), univariate analyzes were used, with measurement of the relative prevalence (RP) ratio and its respective confidence interval of 95% (95%CI) as association estimators. Subsequently, a multivariate logistic regression analysis was performed and all explanatory variables were included in the model (number of pediatric CAP hospitalizations, adjusted age, sex, municipality of residence, vaccination status, vaccination coverage). Chi-square test was used for difference between proportions and independent samples *t* test for difference between means. For all analyzes, a 5% significance level was considered. For storage and analysis of data, the statistical software SPSS 20.0^®^ (IBM SPSS Statistics for Windows, Version 20.0, Armonk, NY, USA) was used.

The research project was submitted to the Institutional Review Board of the Hospital das Clínicas da Faculdade de Medicina de RibeirãoPreto, USP, and was approved on March 19, 2013 (CAAE No: 12487113.5.0000.5440).

Results
=======

This study aimed to evaluate the number of CAP hospitalization among children under one year old, so before the booster shot, which should take place between 12 and 15 months, and vaccination coverage, which occurred in the period that comprised the pre- (2007, 2008 and 2009) and post- (2011, 2012 and 2013) introduction of PCV-10 in the immunization schedule of PNI recommended by the Ministry of Health. [Table 1](#t1){ref-type="table"} shows the number of children in each of the years in the pre- and post-vaccination periods, as well as the number of children included in the study. One should note that, in the period prior to the introduction of PCV-10, the losses were 11.3%, while in the post-vaccine period they were 8.3%. All losses were due to inconsistent records.

###### Distribution of children under one year old enrolled in the 26 municipalities of the SRS/Alfenas, MG; in pre- and post-vaccination periods, as well as raw and mean numbers of children included in the study with their respective losses by period.

  Periods                                                                                  
  --------------------------------- ---------------- ------ ------ ------ ---------------- ------
  5969                              5622             5628   5765   5669   5723             5667
                                    Mean (A)                \-            Mean (B)          
                                    5740                    5765          5686              
  Records (PNI) - SRS/Alfenas, MG                                                          
  2007                              2008             2009   2010   2011   2012             2013
  5107                              5088             5080   5765   5215   5212             5213
                                    Mean (C)                \-            Mean (D)          
                                    5091                    \-            5213              
                                    Losses A-C (%)                        Losses B-D (%)    
                                    11.3                    \-            8.3               

The gross number of the male and female children records between 2007 and 2009 was, respectively, 2632 and 2459 (*p*\<0.05), with an average of nine months (±1) for females and 10 months (±1) for males (*p*\<0.05). Considering the period of 2011-2013, there were 2737 records of male and 2476 records of female children (*p*\<0.05), with respective averages of 9.5±1 months and 10±1.2 months. There was a significant difference (*p*\<0.05).

The number of admissions during the study period is shown in [Fig. 1](#f1){ref-type="fig"}. As it can be noted, the number of CAP admissions in the age group under one year old went from 828 in 2007 to 624 in 2013. There were 5044 cases of CAP admissions during the analysis period.

Figure 1Number of hospitalizations for community-acquired pneumonia (CAP) in children under one year old in 26 municipalities from 2007 to 2013. Coordenadoria de Regulação da SRS/Alfenas, MG, Brazil.

In March 2010, there was the 10-valent pneumococcal conjugate vaccine introduction in the vaccination schedule of children in PNI. Thus, the vaccination coverage that year did not reach the 95% expected coverage ([Table 2](#t2){ref-type="table"}). Therefore, vaccination coverage in 2010 was not evaluated because it could bias the analysis, both due to reduced coverage and the possibility of delay in vaccine seroconversion.

###### Distribution of 10-valent pneumococcal conjugate vaccine coverage in children in 2010, 2011, 2012, and 2013 - SRS/Alfenas, MG, Brazil.

  Municipality      2010                   2011              2012             2013                                   
  ----------------- ---------- ----------- ------ ---------- ------------ --- ---------- ------------ --- ---------- ------------
  Alfenas           524        54.24              937        100.64           843        90.55            927        99.57
  Alterosa          85         49.13              150        88.24            184        108.24           165        97.06
  Arceburgo         23         22.55              76         73.08            117        112.50           99         95.19
  Areado            94         45.41              171        97.16            169        96.02            199        113.07
  Bandeira do Sul   12         19.35              46         75.41            80         131.15           92         150.82
  Botelhos          53         34.42              185        156.78           164        138.98           177        150.00
  Cabo Verde        86         49.14              199        125.16           140        88.05            141        88.68
  Campestre         115        49.36              215        101.90           184        87.20            235        111.37
  C. do Meio        52         45.22              142        112.70           161        127.78           121        96.03
  C. Gerais         183        55.62              330        100.30           291        88.45            332        100.91
  C. Rio Claro      100        54.35              168        83.17            195        96.53            195        96.53
  Carvalhópolis     23         46.00              43         107.50           43         107.50           42         105.00
  Conc. Aparecida   74         57.81              145        131.82           144        130.91           103        93.64
  Divisa Nova       60         71.43              84         123.53           82         120.59           77         113.24
  Fama              5          20.00              20         86.96            24         104.35           31         134.78
  Guaranésia        95         45.89              236        95.16            244        98.39            243        97.98
  Guaxupé           387        61.23              645        105.56           708        115.88           633        103.60
  Juruaia           73         89.02              90         84.11            128        119.63           131        122.43
  Machado           285        58.52              519        102.57           463        91.50            461        91.11
  Monte Belo        68         62.39              116        84.67            150        109.49           146        106.57
  Muzambinho        120        50.21              264        112.34           243        103.40           253        107.66
  Nova Resende      107        56.02              234        121.88           206        107.29           208        108.33
  Paraguaçu         107        47.35              254        102.01           271        108.84           245        98.39
  PoçoFundo         103        65.19              157        95.15            176        106.67           182        110.30
  S. P. da União    14         33.33              52         130.00           59         147.50           57         142.50
  Serrania          30         30.30              104        101.96           107        104.90           93         91.18
  **Total**         **2878**   **52.72**          **5582**   **102.99**       **5576**   **102.88**       **5588**   **103.10**

[Fig. 2](#f2){ref-type="fig"} shows the overall number of CAP admissions in periods pre- and post-introduction of the vaccine in PNI, considering all the municipalities of SRS/Alfenas. When considering the group of municipalities that comprises the SRS/Alfenas, there was a significant difference of−13.20% (95%CI:−44.08% to−15.31%; *p*\<0.05) in the incidence of pediatric CAP hospitalizations between the study periods.

Figure 2Total distribution of CAP cases in children, registered in the municipalities of SRS Alfenas, MG, Brazil before (2007-2009) and after (2011-2013) the start of immunization with 10-valent pneumococcal conjugate vaccine.

Multivariate analysis between vaccination status and the occurrence of CAP hospitalization in each of the 26 municipalities, adjusted for confounding variables, as well as of SRS as a whole, can be seen in [Table 3](#t3){ref-type="table"}.

###### Analysis of the association between vaccination and the incidence of community-acquired pneumonia in children from 26 municipalities of the SRS/Alfenas, MG, Brazil, comparing the years 2007-2009 (before pneumococcal immunization) with the years 2011-2013 (after introduction of pneumococcal vaccine).

  Municipality             PR         95%CI           *p*-value
  ------------------------ ---------- --------------- ----------------------------------------------
  Alfenas                  1.07       0.81-1.42       \>0.05
  Alterosa                 0.36       0.13-0.95       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Arceburgo                0.22       0.05-0.90       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Areado                   0.59       0.24-1.47       \>0.05
  B.do Sul                 0.33       0.07-1.65       \>0.05
  Botelhos                 1.02       0.44-2.38       \>0.05
  Cabo Verde               1.26       0.79-1.99       \>0.05
  Campestre                0.71       0.35-1.41       \>0.05
  Campo do Meio            0.48       0.30-0.77       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Campos Gerais            0.59       0.41-0.87       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Carmo do Rio Claro       0.86       0.54-1.37       \>0.05
  Carvalhópolis            0.90       0.30-2.70       \>0.05
  Conceição da Aparecida   0.53       0.21-1.35       \>0.05
  Divisa Nova              1.88       0.32-10.90      \>0.05
  Fama                     0.41       0.04-4.20       \>0.05
  Guaranésia               0.23       0.15-0.36       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Guaxupé                  1.27       1.08-1.50       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Juruaia                  0.57       0.37-0.88       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Machado                  0.63       0.40-0.90       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Monte Belo               0.48       0.24-0.97       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  Muzambinho               0.88       0.41-1.91       \>0.05
  Nova Resende             0.72       0.44-1.19       \>0.05
  Paraguaçu                1.04       0.54-1.89       \>0.05
  Poço Fundo               0.37       0.15-0.89       \<0.05^[a](#TFN1){ref-type="table-fn"}^
  São Pedro                3.15       0.67-14.70      \>0.05
  Serrania                 1.14       0.44-2.90       \>0.05
  SRS Alfenas (Global)     **0.81**   **0.74-0.89**   **\<0.05** ^[a](#TFN1){ref-type="table-fn"}^

PR, prevalence ratio; 95%CI, 95% confidence interval.

Significant.

In the municipalities of Alfenas, Areado, Bandeira do Sul, Botelhos, Cabo Verde, Campestre, Carmo do Rio Claro, Carvalhópolis, Conceição da Aparecida, Divisa Nova, Fama, Muzambinho, Nova Resende, Paraguaçu, São Pedro da União, and Serrania there were no differences in CAP prevalence between vaccinated and unvaccinated children. In the municipalities of Alterosa, Arceburgo, Campo do Meio, Campos Gerais, Guaranésia, Juruaia, Machado, Monte Belo, and Poço Fundo there was a decrease in CAP hospitalization in vaccinated versus unvaccinated children, as shown in [Fig. 3](#f3){ref-type="fig"}. In the municipality of Guaxupé there was a significant 27% increase in CAP hospitalization between the two study periods (pre- and post-vaccination). This phenomenon requires further clarification. In all the 26 municipalities, vaccination may have been responsible for a 19% reduction in hospitalizations due to CAP cases in children under one year old. During this period, there was no mortality from CAP in children under one year old in all the municipalities of the SRS/Alfenas.

Figure 3Representation of the prevalence ratio (PR) specific values relating to CAP hospitalization in children up to one year old, in each of the 26 municipalities, and considering the total value of SRS-Alfenas, MG, Brazil, after the introduction of the PCV-10 vaccine. Columns represent the values of prevalence ratio of CAP hospitalization after the introduction of the PCV-10 vaccine. Horizontal line represents the prevalence ratio=1; i.e., the non-changing line in the prevalence of CAP after introduction of the PCV-10 vaccine.

Discussion
==========

This study showed a 19% reduction in CAP in children younger than one year between 2007-2009 and 2011-2013, corresponding to the periods before and after the introduction of the immunization schedule of PCV-10 in 2010 in the PNI, in 26 municipalities under the jurisdiction of SRS/Alfenas.

The Ministry of Health recommends 95% as the ideal rate of vaccination coverage able to give efficiency to the 10-valent pneumococcal vaccine to reduce cases of CAP and other invasive pneumococcal diseases.[@B11] ^,^ [@B12] ^,^ [@B14] In this study, the average coverage rate in the year that the vaccine was introduced was only 52.7%; however, in 2011, 2012, and 2013 the rates were 104.0%, 102.9%, and 103.1%, respectively, which is above the recommended. It is expected, therefore, a reduction in the number of CAP cases and its consequences, such as hospitalization and mortality, which was actually seen. This finding is similar to that of a study by Afonso et al.[@B15] reporting a reduction of pneumonia cases in cities where the coverage was over 95%, unlike the cities with lower coverage, such as São Paulo (75%) and Porto Alegre (85%), where such a reduction was not seen. In our study, as shown in [Table 2](#t2){ref-type="table"}, many municipalities showed vaccine coverage above 100%. This probably happened due to two important facts. The first refers to the intense seasonal migration in the municipalities during the coffee harvest period. Rural workers and their families who seek vaccination centers are vaccinated according to their respective age groups. The second fact could be the extensive rural area that many municipalities have. Thus, for many families, the distance from another city vaccination center is shorter than that of their own cities.

In addition to the aspects directly related to CAP morbidity and mortality, with impact on quality of life of children and their parents, there is the economic issue associated with the disease; for example, the cost linked to its management (spending on antibiotics, hospitalization, clinical tests, parental absence from work, and others). Thus, some studies have shown that children vaccination against pneumococcus is cost-effective from the perspective of society, reduces the total burden of pneumococcal disease, including CAP. Martí et al.[@B11] analyzed the cost-effectiveness based on quality-adjusted life year (QALY) of PCV-10 in six Latin American countries, including Brazil, and reported that the incorporation of immunization is a cost-effective strategy in improving health standards of the pediatric population.

In analyzing the periods before and after the introduction of PCV-10 in PNI, as shown in [Fig. 1](#f1){ref-type="fig"}, the number of CAP hospitalizations in the 26 selected municipalities had shown a decline from 2009 (pre-vaccine period), a fact that can certainly be explained by better sanitary conditions, increased household income, as well as gains in children health care seen in recent years throughout Brazil. Thus, vaccination against pneumococcus brought an increase to the decline observed in its post-introduction period since 2010.[@B16] ^-^ [@B19]

One limitation of the present study is the fact that it is an ecological study in which the observed unit is not the individual, but a group of people representing a portion of the population that is under the jurisdiction of SRS/Alfenas (children under one year old); however, we used official sources that have quality control---Datasus, SI-PNI, and Tabwin---available in the Regulation Center of SRS/Alfenas, but still it may have flaws, which was observed in the loss of records in the least 8.3% of cases in the post-vaccination period. Other limiting aspects of this study are related to potential confounding factors, such as the improvement in children\'s dietary patterns, observed in the last decade, contributing to a decreased incidence of severe CAP, in addition to vaccination, presence of some comorbidities, and differences in the prevalence of PAC between male and female.[@B18] ^,^ [@B20] Finally, another limitation is the fact only children were assessed before the recommended booster shot between 12 and 15 months.

In the PCV-10 post-advent period, there was a decreased number of PAC in children under 12 months old in the region of SRS/Alfenas, MG, Brazil. In countries where pneumococcal conjugate and even polysaccharide vaccines were established and maintained with high vaccination coverage, the reduction of invasive pneumococcal disease is significant; the same result was found in this study, which showed a reduction in the number of CAP children hospitalized in the study period.
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